Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Kowinnnisteon Feb 07, 2018 1:15pm
78 Views
Post# 27520314

RE:RE:RE:RE:All the great news from Dec and Jan

RE:RE:RE:RE:All the great news from Dec and JanQ2 , they made 2.7M$, I don't think they did 900K$ equally each month, since Q1 was close to no revenue. So Iet's say maybe 500K$, then 1.0M$ and 1.2M$ for a total of 2.7M$.

Q3 = 5M$. again I don't think they did 1.6M$ every month. Let's say 1.4M$, 1.7M$ then 1.9M$.

Q4 = Even if new aquisition I am pretty sure their sale have increased a bit (not exponentially..yet).
My estimate 2.2M$, 2.5M$, 2.8M$ = 7.5M$.

I'll be happy with that.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities